People
Imagine if an ultrasound could be used as a quantitative tool to measure fat in the liver and detect non-alcoholic fatty liver disease. What seems imaginative is close to becoming reality at Endra Life Sciences.
Flamma SpA is proud to announce that Mr. Gian Paolo Negrisoli, Flamma CEO, has been granted Honorary Dalian Citizenship for his friendship to China and his contribution in promoting economic exchanges and cooperation through Flamma Honkai.
Aligos Therapeutics, Inc., a biotechnology company focused on the development of targeted therapies for hepatologic diseases and viral infections, including chronic hepatitis B, nonalcoholic steatohepatitis, and hepatocellular carcinoma, announced the appointment of Kathleen Sereda Glaub to the company’s board of directors.
Corporate culture is interesting because it affects almost every aspect of a business.
Rezolute, Inc., a biopharmaceutical company specializing in the development of innovative drug therapies for patients with metabolic diseases, announced the appointment of Gil Labrucherie to its Board of Directors where he will serve as Chairman of the Audit Committee.
The company has doubled its headcount to about 60 employees and doubled its square-footage in the city with the 26,000 square-foot facility.
MorphoSys AG announced that Dr. Markus Enzelberger, the company’s Chief Scientific Officer, has decided to step down as CSO and member of the company’s Management Board to explore new opportunities. Dr. Enzelberger will leave MorphoSys on February 29, 2020.
Pelican BioThermal, the global name in temperature-controlled packaging, announces the appointment of Ed Meyer, general manager for Canada sales and operations of parent company Pelican Products, Inc., to the global sales leadership role for the BioThermal division.
Pharma and biotech companies strengthen their leadership teams and boards with this week’s appointments.
A peculiarity of autoimmune diseases is that they have many genes in common, but they develop differently.
PRESS RELEASES